Back to Our Insights

Medtech Insights

Article

Accelerating growth in medtech: The next surge in portfolio moves

– Large medtech companies are struggling with growth challenges and stagnant valuations. Could M&A and divestitures reset the... trajectory?
Article

How medtech companies can create value with new-business building

– Medtech industry senior executives recently convened to discuss new-business building. Their experiences illuminate what it can... do for companies, why it’s so difficult, and how to get it right.
Article

From extreme to mainstream: The future of aesthetics injectables

– McKinsey research shows that the global aesthetics injectables market could grow by 12 to 14 percent a year over the next five... years if manufacturers and providers capitalize on the underlying trends.
Article

Omnichannel engagement in medtech: The time is now

– Leading medtech companies are shifting to omnichannel models to build personalized engagement and stronger relationships with... healthcare professionals, which will ultimately translate into better care for patients.
Article

How the medtech industry can capture value from digital health

– Medtech companies could play a major role in the digital transformation of healthcare that is under way, but they will have to... make some big changes to the way they operate—and fast.
Article

How Japan’s medtech leaders can use M&A to create a competitive advantage

– Companies that invest inorganically during a downturn generally emerge stronger than their competitors. Japanese medtech companies... have the cash, the incentive, and the opportunity to do just that.
Article

The resilience imperative for medtech supply chains

– The COVID-19 pandemic highlighted issues with supply chains around the world. As medtech companies prepare for the next normal,... they have a mandate to rebuild their supply chains with resilience as a new priority.
Interview

Medtech innovation in the time of COVID-19: Resilience and growth during a crisis

– COVID-19 is a threat but also a call to action for organizations improving the delivery of healthcare services. Executives from... four leading medtech firms share how they have thrived during this crisis by applying their business-building capabilities.
Article

Medtech’s call to action: Meeting the demand surge caused by COVID-19

– Five interventions have helped manufacturers ease supply constraints for medtech products during the pandemic. Important lessons... have been learned along the way.
Interview

Thermo Fisher Scientific CEO Marc Casper on provisioning the front lines in the pandemic

– Governments, healthcare providers, and pharmaceutical companies are battling COVID-19 on different fronts. Thermo Fisher Scientific... is at the nexus of all of these endeavors.
Article

How COVID-19 is reshaping China’s medtech industry

– With COVID-19 accelerating the underlying trends in China’s medtech industry, new business models are likely to emerge.
Sorry, we couldn't find any results. Try removing some filters.

Related Insight

Scanning the future of medical imaging

December 2018 – Innovation, new business models, and new technologies are driving change in the medical device industry. This article maps start-ups and trends shaping the future of medical imaging, identifying clusters of technology and their growth prospects, as well as highlighting the implications these may have.